A new variant of apolipoprotein E (apo E Maebashi) in lipoprotein glomerulopathy

被引:0
|
作者
T. Ogawa
K. Maruyama
H. Hattori
H. Arai
I. Kondoh
T. Egashira
T. Watanabe
Y. Kobayashi
A. Morikawa
机构
[1] Department of Pediatrics,
[2] Gunma University School of Medicine,undefined
[3] 3-39-22 Showa-machi,undefined
[4] Maebashi,undefined
[5] Gunma,undefined
[6] 371-8511 Japan Tel.: +81-27-220-8205,undefined
[7] Fax: +81-27-220-8215,undefined
[8] Research Department,undefined
[9] R and D Center,undefined
[10] BML,undefined
[11] Inc.,undefined
[12] Kawagoe,undefined
[13] Saitama,undefined
[14] Japan,undefined
来源
Pediatric Nephrology | 2000年 / 14卷
关键词
Key words Lipoprotein glomerulopathy; Deletion mutation; Apolipoprotein E; Novel variant protein; DNA sequence analysis;
D O I
暂无
中图分类号
学科分类号
摘要
We have previously reported an 8-year-old girl with lipoprotein glomerulopathy. Assessment of serum apolipoprotein E (apo E) in this patient showed a discrepancy between phenotype and genotype, suggesting that she may have a variant of apo E. The present report concerns our analysis of DNA sequences of the apo E gene in the patient: nine base pairs were found to be deleted from exon 4. This mutation would appear to encode a new apo E variant lacking three amino acids. This variant may be associated with the pathogenesis of lipoprotein glomerulopathy.
引用
收藏
页码:149 / 151
页数:2
相关论文
共 50 条
  • [21] Lipoprotein glomerulopathy: Renal lipidosis induced by novel apolipoprotein E variants
    Saito, T
    Oikawa, S
    Sato, H
    Sasaki, J
    NEPHRON, 1999, 83 (03) : 193 - 201
  • [22] Common Apolipoprotein E Gene Mutations Contribute to Lipoprotein Glomerulopathy in China
    Han, Jia
    Pan, Yongli
    Chen, Yuqing
    Li, Xia
    Xing, Guangqun
    Shi, Junhua
    Hou, Ping
    Zhang, Hong
    Wang, Haiyan
    NEPHRON CLINICAL PRACTICE, 2010, 114 (04): : C260 - C267
  • [23] Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy
    ZHANG Bo LIU Zhihong ZENG Caihong ZHENG Jingmin CHEN Huiping ZHOU Hong and LI LeishiResearch Institute of Nephrology Jingling Hospital Nanjing University School of Medicine Nanjing ChinaDepartment of Nephrology First Affiliated Hospital of Nanjing Medical University Nanjing China
    Chinese Medical Journal, 2005, (07) : 555 - 560
  • [24] Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy
    Zhang, B
    Liu, ZH
    Zeng, CH
    Zheng, JM
    Chen, HP
    Zhou, H
    Li, LS
    CHINESE MEDICAL JOURNAL, 2005, 118 (07) : 555 - 560
  • [26] Role of apolipoprotein E variants in lipoprotein glomerulopathy and other renal lipidoses
    Saito T.
    Ishigaki Y.
    Oikawa S.
    Yamamoto T.T.
    Clinical and Experimental Nephrology, 2001, 5 (4) : 201 - 208
  • [27] Lipoprotein glomerulopathy: A new apolipoprotein-E-related disease that recurs after renal transplantation
    Mourad, G
    Cristol, JP
    TurcBaron, C
    Djamali, A
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (05) : 2376 - 2376
  • [28] A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy
    Bomback, Andrew S.
    Song, Huijuan
    D'Agati, Vivette D.
    Cohen, Scott D.
    Neal, Alison
    Appel, Gerald B.
    Rovin, Brad H.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (10) : 3442 - 3446
  • [29] Apolipoprotein E Mutation and Double Filtration Plasmapheresis Therapy on a New Chinese Patient with Lipoprotein Glomerulopathy
    Li, Wencheng
    Wang, Yang
    Han, Zhiwu
    Luo, Changqing
    Zhang, Chun
    Xiong, Jing
    KIDNEY & BLOOD PRESSURE RESEARCH, 2014, 39 (04): : 330 - 339
  • [30] A NEW APO-E VARIANT IN CAUCASIANS
    MAILLY, F
    XHIGNESSE, M
    KESSLING, AM
    MILNE, RW
    LUSSIERCACAN, S
    DAVIGNON, J
    NESTRUCK, AC
    ARTERIOSCLEROSIS, 1988, 8 (05): : A614 - A614